Literature DB >> 7809113

Tumor necrosis factor alpha-induced phosphorylation of I kappa B alpha is a signal for its degradation but not dissociation from NF-kappa B.

S Miyamoto1, M Maki, M J Schmitt, M Hatanaka, I M Verma.   

Abstract

Activation of the NF-kappa B/Rel family of transcription factors is regulated by a cytoplasmic inhibitor, I kappa B alpha. Activity of I kappa B alpha is in turn modulated by phosphorylation and proteolysis. It has been postulated that phosphorylation of I kappa B alpha leads to its dissociation from NF-kappa B, and free I kappa B alpha is targeted for rapid degradation. However, this phosphorylation-mediated dissociation event has not been demonstrated in vivo. We demonstrate that, contrary to this hypothesis, phosphorylation of I kappa B alpha induced by tumor necrosis factor alpha in HeLa cells does not induce dissociation. We propose a model in which (i) induced phosphorylation of I kappa B alpha does not result in its dissociation from NF-kappa B, (ii) phosphorylation of I kappa B alpha serves as a signal for degradation, and (iii) degradation of I kappa B alpha occurs while it is still complexed with NF-kappa B.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7809113      PMCID: PMC45515          DOI: 10.1073/pnas.91.26.12740

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  21 in total

Review 1.  PEST sequences are signals for rapid intracellular proteolysis.

Authors:  M Rechsteiner
Journal:  Semin Cell Biol       Date:  1990-12

Review 2.  NF-kappa B and Rel: participants in a multiform transcriptional regulatory system.

Authors:  M Grilli; J J Chiu; M J Lenardo
Journal:  Int Rev Cytol       Date:  1993

3.  Autoregulation of I kappa B alpha activity.

Authors:  P J Chiao; S Miyamoto; I M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-04       Impact factor: 11.205

4.  NF-kappa B controls expression of inhibitor I kappa B alpha: evidence for an inducible autoregulatory pathway.

Authors:  S C Sun; P A Ganchi; D W Ballard; W C Greene
Journal:  Science       Date:  1993-03-26       Impact factor: 47.728

5.  Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of I kappa B alpha: a mechanism for NF-kappa B activation.

Authors:  A A Beg; T S Finco; P V Nantermet; A S Baldwin
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

6.  Direct association of pp40/I kappa B beta with rel/NF-kappa B transcription factors: role of ankyrin repeats in the inhibition of DNA binding activity.

Authors:  J Inoue; L D Kerr; D Rashid; N Davis; H R Bose; I M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

7.  The p65 subunit of NF-kappa B regulates I kappa B by two distinct mechanisms.

Authors:  M L Scott; T Fujita; H C Liou; G P Nolan; D Baltimore
Journal:  Genes Dev       Date:  1993-07       Impact factor: 11.361

8.  Rapid proteolysis of I kappa B-alpha is necessary for activation of transcription factor NF-kappa B.

Authors:  T Henkel; T Machleidt; I Alkalay; M Krönke; Y Ben-Neriah; P A Baeuerle
Journal:  Nature       Date:  1993-09-09       Impact factor: 49.962

9.  I kappa B/MAD-3 masks the nuclear localization signal of NF-kappa B p65 and requires the transactivation domain to inhibit NF-kappa B p65 DNA binding.

Authors:  P A Ganchi; S C Sun; W C Greene; D W Ballard
Journal:  Mol Biol Cell       Date:  1992-12       Impact factor: 4.138

10.  Common structural constituents confer I kappa B activity to NF-kappa B p105 and I kappa B/MAD-3.

Authors:  E N Hatada; M Naumann; C Scheidereit
Journal:  EMBO J       Date:  1993-07       Impact factor: 11.598

View more
  63 in total

1.  Cytoplasmic catalytic subunit of protein kinase A mediates cross-repression by NF-kappa B and the glucocorticoid receptor.

Authors:  V Doucas; Y Shi; S Miyamoto; A West; I Verma; R M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

2.  Constitutive expression of Bc1-3 in thymocytes increases the DNA binding of NF-kappaB1 (p50) homodimers in vivo.

Authors:  J H Caamaño; P Perez; S A Lira; R Bravo
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

3.  Mapping of the inducible IkappaB phosphorylation sites that signal its ubiquitination and degradation.

Authors:  J DiDonato; F Mercurio; C Rosette; J Wu-Li; H Suyang; S Ghosh; M Karin
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

4.  A new member of the I kappaB protein family, I kappaB epsilon, inhibits RelA (p65)-mediated NF-kappaB transcription.

Authors:  Z Li; G J Nabel
Journal:  Mol Cell Biol       Date:  1997-10       Impact factor: 4.272

5.  Proteasome inhibitors induce apoptosis of prostate cancer cells by inducing nuclear translocation of IkappaBalpha.

Authors:  Hai-Yen Vu; Ashish Juvekar; Chandra Ghosh; Sitharam Ramaswami; Dung Hong Le; Ivana Vancurova
Journal:  Arch Biochem Biophys       Date:  2008-04-29       Impact factor: 4.013

6.  Identification by in vivo genomic footprinting of a transcriptional switch containing NF-kappaB and Sp1 that regulates the IkappaBalpha promoter.

Authors:  M Algarté; H Kwon; P Génin; J Hiscott
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

7.  Involvement of regulatory and catalytic subunits of phosphoinositide 3-kinase in NF-kappaB activation.

Authors:  C Béraud; W J Henzel; P A Baeuerle
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-19       Impact factor: 11.205

8.  Characterization of a mutant cell line that does not activate NF-kappaB in response to multiple stimuli.

Authors:  G Courtois; S T Whiteside; C H Sibley; A Israel
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

9.  Signal-induced degradation of I kappa B alpha requires site-specific ubiquitination.

Authors:  D C Scherer; J A Brockman; Z Chen; T Maniatis; D W Ballard
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

10.  Stimulation-dependent I kappa B alpha phosphorylation marks the NF-kappa B inhibitor for degradation via the ubiquitin-proteasome pathway.

Authors:  I Alkalay; A Yaron; A Hatzubai; A Orian; A Ciechanover; Y Ben-Neriah
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.